Recurrent thyroid gland carcinoma Clinical Trials

Delta Trials indexes 14 clinical trials for Recurrent thyroid gland carcinoma in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 8 trials have reached completion. This research takes place spanning 814 research sites around the world. An additional 6 trials are in preparatory or other active non-recruiting stages. Since 2020, 1 trial were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.